Delivery Order SPE2DB20D1004-SPE2DB23FG5N4
Award Date
9/13/23
Potential Completion Date
9/14/23
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,874.12 firm fixed-price delivery order is for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat enlarged prostate. The contract has an ultimate completion date of June 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,106.32 firm fixed-price delivery order is for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat an enlarged prostate. The contract has a completion date of June 11, 2024 and was awarded on June 10, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $5,145.40 firm fixed-price delivery order is for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat enlarged prostate. The contract has an ultimate completion date of May 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,080.54 firm fixed-price delivery order is for the supply of 1,000 bottles of Tamsulosin HCl 0.4 mg capsules, a medication used to treat symptoms of an enlarged prostate. The contract has a period of performance through March 5, 2024 and is not associated with any set-aside designations. AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,914.22, is for the delivery of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat enlarged prostate. The award is a Delivery Order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication commonly used to treat enlarged prostate. The $7,313.65 Firm Fixed Price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is the primary agency responsible for procuring pharmaceutical and medical supplies for the Department of Defense and other federal healthcare programs. The contract...
This federal contract award, valued at $1,687.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,564,978,039 units of Tamsulosin HCL 0.4 mg capsules, a medication used to treat an enlarged prostate. The contract has a completion date of June 24, 2024 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,004.76 firm-fixed-price contract is for the delivery of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat an enlarged prostate. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,093.29, is for the delivery of Tamsulosin HCL 0.4 mg capsules, a medication used to treat an enlarged prostate. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 13, 2024. It is not designated as a set-aside contract. AmerisourceBergen...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency. The $1,152.16 Firm Fixed Price Delivery Order contract is for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat an enlarged prostate. The contract has an ultimate completion date of February 5, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) with the Defense Logistics...